Abbott, AstraZeneca sales and marketing update

AstraZeneca granted Abbott non-exclusive rights to co-promote Crestor rosuvastatin in the U.S., excluding Puerto Rico. AstraZeneca markets the HMG-CoA reductase inhibitor to treat primary hyperlipide...